The oncogenic driving capacity of GATA3 originated from the induction of the transcriptional programs that promote cell growth and proliferation; hence, divergent enhancer landscapes were detected among GATA-3-associated T-cell neoplasms with different target genes [44]. Here, GATA3 is linked to T-cell and NK-cell neoplasm.